From the Mayo Clinic College of Medicine, Mayo Clinic Scottsdale, Scottsdale, AZ.
Duration of Migraine Is a Predictor for Response to Botulinum Toxin Type A
Article first published online: 5 APR 2005
Headache: The Journal of Head and Face Pain
Volume 45, Issue 4, pages 308–314, April 2005
How to Cite
Eross, E. J., Gladstone, J. P., Lewis, S., Rogers, R. and Dodick, D. W. (2005), Duration of Migraine Is a Predictor for Response to Botulinum Toxin Type A. Headache: The Journal of Head and Face Pain, 45: 308–314. doi: 10.1111/j.1526-4610.2005.05067.x
- Issue published online: 5 APR 2005
- Article first published online: 5 APR 2005
- Accepted for publication December 1, 2004.
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.